Literature DB >> 16404556

Hepatoblastoma: an oncological review.

Derek J Roebuck1, Giorgio Perilongo.   

Abstract

The treatment of hepatoblastoma is an example of the great advances made in paediatric oncology over the past few decades. Formerly a disease with a dreadful prognosis, children now have a 5-year survival rate of over 70%. This has been achieved by advances in surgical techniques and the use of chemotherapy. In future, we hope to be able to improve survival for children with high-risk tumours, and decrease the morbidity associated with treatment in the others.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404556     DOI: 10.1007/s00247-005-0064-3

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  29 in total

1.  Prognostic factors and staging systems in childhood hepatoblastoma.

Authors:  D von Schweinitz; H Hecker; G Schmidt-von-Arndt; D Harms
Journal:  Int J Cancer       Date:  1997-12-19       Impact factor: 7.396

2.  Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.

Authors:  J A Ortega; E C Douglass; J H Feusner; M Reynolds; J J Quinn; M J Finegold; J E Haas; D R King; W Liu-Mares; M G Sensel; M D Krailo
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

3.  Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.

Authors:  M R DeBaun; M A Tucker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

4.  Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.

Authors:  J Pritchard; J Brown; E Shafford; G Perilongo; P Brock; C Dicks-Mireaux; J Keeling; A Phillips; A Vos; J Plaschkes
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

5.  Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.

Authors:  J E Haas; K A Muczynski; M Krailo; A Ablin; V Land; T J Vietti; G D Hammond
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

6.  Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin.

Authors:  Andrzej Prokurat; Przemysław Kluge; Andrzej Kościesza; Danuta Perek; Andreas Kappeler; Arthur Zimmermann
Journal:  Med Pediatr Oncol       Date:  2002-11

7.  Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.

Authors:  J Lemerle; P A Voute; M F Tournade; C Rodary; J F Delemarre; D Sarrazin; J M Burgers; B Sandstedt; H Mildenberger; M Carli
Journal:  J Clin Oncol       Date:  1983-10       Impact factor: 44.544

8.  Hepatoblastoma and hepatocellular carcinoma in children.

Authors:  Hsin-Lin Tsai; Chin-Su Liu; Tai-Wai Chin; Chou-Fu Wei
Journal:  J Chin Med Assoc       Date:  2004-02       Impact factor: 2.743

9.  Adriamycin and cisplatin for hepatoblastoma.

Authors:  J J Quinn; A J Altman; H T Robinson; R W Cooke; D W Hight; J H Foster
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

10.  Childhood cancer.

Authors:  R W Miller; J L Young; B Novakovic
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

View more
  14 in total

1.  Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.

Authors:  Eun Shin; Kyoung-Bun Lee; Soo-Young Park; Soo-Hee Kim; Han-Suk Ryu; Young-Nyun Park; Eunsil Yu; Ja-June Jang
Journal:  Virchows Arch       Date:  2011-03-03       Impact factor: 4.064

2.  Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children.

Authors:  Masakazu Hirakawa; Akihiro Nishie; Yoshiki Asayama; Nobuhiro Fujita; Kousei Ishigami; Tatsurou Tajiri; Tomoaki Taguchi; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-06-13       Impact factor: 2.374

3.  Altered microRNA Expression Patterns in Hepatoblastoma Patients.

Authors:  Armando Magrelli; Gianluca Azzalin; Marco Salvatore; Mara Viganotti; Fabrizio Tosto; Teresa Colombo; Rita Devito; Alessandra Di Masi; Antonio Antoccia; Stefano Lorenzetti; Francesca Maranghi; Alberto Mantovani; Caterina Tanzarella; Giuseppe Macino; Domenica Taruscio
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

4.  Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.

Authors:  Katalin Dezso; Judit Halász; Hanne Cathrine Bisgaard; Sándor Paku; Eszter Turányi; Zsuzsa Schaff; Peter Nagy
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

5.  Predictors of survival and incidence of hepatoblastoma in the paediatric population.

Authors:  Bassan J Allan; Punam P Parikh; Sofia Diaz; Eduardo A Perez; Holly L Neville; Juan E Sola
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

6.  Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence.

Authors:  Jingjing Ye; Qiang Shu; Minju Li; Tian-an Jiang
Journal:  Pediatr Radiol       Date:  2008-06-06

7.  Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines.

Authors:  Alexander J Neuwelt; Y Jeffrey Wu; Narcyz Knap; Marcin Losin; Edward A Neuwelt; Michael A Pagel; Steven Warmann; Joerg Fuchs; Piotr Czauderna; Michal Wozniak
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

8.  Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.

Authors:  Carmen Eicher; Alexander Dewerth; Verena Ellerkamp; Joerg Fuchs; Sarah Schott; Sorin Armeanu-Ebinger
Journal:  Pediatr Surg Int       Date:  2013-02       Impact factor: 1.827

Review 9.  Pitfalls in paediatric oncology imaging.

Authors:  K Wessely; L Biassoni; K McHugh
Journal:  Cancer Imaging       Date:  2011-09-24       Impact factor: 3.909

10.  Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge.

Authors:  Alexander Moll; Alexander Krenauer; Uta Bierbach; Holger Till; Wolfgang Hirsch; Ivo Leuschner; Nicole Schmitz; Christian Wittekind; Thomas Aigner
Journal:  Diagn Pathol       Date:  2009-11-12       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.